VibroSense Dynamics AB (publ) – Diabetes Foot Screening application approved in ongoing validation study and ready for market launch
VibroSense Dynamics AB (VibroSense) clinical validation study for the new application Diabetes Foot Screening, shows that the company's product VibroSense Meter® II meets all essential criteria for approval according to the clinical validation plan. VibroSense thus keeps the schedule the company has previously communicated and is ready to launch the Diabetes Foot Screening application to both primary and specialist care.During the fall of 2020, VibroSense Dynamics AB has conducted a clinical validation study with the new application Diabetes Foot Screening, designed for the company's